 Business Update
November 9, 2024
As the holiday season approaches, dog lovers are in for a treat as BARK (NYSE: BARK), a leading global omnichannel dog brand, unveils a slew of festive offerings designed to bring joy to both dogs and their owners. For the first time ever, BARK is introducing its popular BarkBox subscription service to retail throug...
|
Business Update
November 9, 2024
Scheduling the Future: NYSE Group s Holiday Calendar and Its Broader Implications In an era where financial markets are continually abuzz with activity from dawn to dusk, the announcement of future holiday and early closing schedules by the NYSE Group a key component of Intercontinental Exchange Inc. (NYSE: ICE) off...
|
Business Update
November 9, 2024
Aditxt, Inc. Updates Shareholders on Strategic Financial Moves and Acquisition Efforts Amid a Reverse Stock Split MOUNTAIN VIEW, Calif. Aditxt, Inc. (NASDAQ: ADTX), a dynamic innovation platform devoted to accelerating promising health technologies, has released a significant update for its shareholders, sheddin...
|
|
 Business Update
November 9, 2024
In a significant development within the realm of corporate transactions, Ademi LLP has initiated an investigation into EMCORE Corporation (Nasdaq: EMKR) regarding potential breaches of fiduciary duty and other violations of law in connection with its transaction with Velocity One. This examination comes at a critica...
 Business Update
November 9, 2024
Innovative RF Switch by Mobix Labs Wins Gold in 2024 LEAP Awards In a significant recognition of technological advancement, Mobix Labs Inc. (Nasdaq: MOBX) was awarded the prestigious Gold Award in the 2024 Leadership in Engineering Achievement Program (LEAP) Awards. Based in Irvine, California, Mobix Labs is renowne...
|
|
Our most Popular Articles
|
Business Update
December 10, 2024
In an exciting new development in the field of dermatological therapeutics, Astria Therapeutics Inc. (Nasdaq: ATXS) announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for STAR-0310. This groundbreaking monoclonal antibody, an OX40 antagonist, is bein...
|
Business Update
November 5, 2024
Expanding Horizons: JetBlue s New Caribbean Connections As JetBlue Airways makes strategic advances and fortifies its aviation empire, the skies over the Caribbean have become a significant focal point. This week, the airline marked another milestone by inaugurating a new nonstop service between New York s John F. K...
|
Announcement
April 2, 2025
In an unfolding legal development, investors in Maravai Lifesciences Holdings, Inc. a prominent biotech firm, are being advised to take swift action regarding a significant securities class action lawsuit. According to a recent statement from the Rosen Law Firm, a leading global investor rights law firm, the deadlin...
|
|
|
Company News
|
Business Update
November 9, 2024
Scheduling the Future: NYSE Group s Holiday Calendar and Its Broader Implications In an era where financial markets are continually abuzz with activity from dawn to dusk, the announcement of future holiday and early closing schedules by the NYSE Group a key component of Intercontinental Exchange Inc. (NYSE: ICE) off...
|
Business Update
November 9, 2024
Aditxt, Inc. Updates Shareholders on Strategic Financial Moves and Acquisition Efforts Amid a Reverse Stock Split MOUNTAIN VIEW, Calif. Aditxt, Inc. (NASDAQ: ADTX), a dynamic innovation platform devoted to accelerating promising health technologies, has released a significant update for its shareholders, sheddin...
|
Product Service News
November 9, 2024
Autolus Therapeutics has recently announced the FDA approval of AUCATZYL (obecabtagene autoleucel or obe-cel) for the treatment of adults suffering from relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL). This pivotal decision follows a recognized need for more effective treatment options for ...
|
|
|
Company News
 Clinical Study
November 9, 2024
|
Company News
 Product Service News
November 9, 2024
|
Company News
 Merger and Acquisition
November 9, 2024
|
More Company News
|
Business Update
November 9, 2024
|
Clinical Study
November 9, 2024
|
Announcement
November 9, 2024
|
Contract
November 9, 2024
|
Announcement
November 9, 2024
|
Clinical Study
November 9, 2024
|
Business Update
November 9, 2024
|
Product Service News
November 9, 2024
|
Partnership
November 9, 2024
|
Contract
November 9, 2024
|
|
|
|
Related News
|
Announcement
|
Business Update
|
|
Stocks
|
Business Update
|
Business Update
|
Business Update
|
|
|
|
Business News
|
 Business Update
In a significant development within the realm of corporate transactions, Ademi LLP has initiated an investigation into EMCORE Corporation (Nasdaq: EMKR) regarding potential breaches of fiduciary duty and other violations of law in connection with its transaction with Velocity One. This examination comes at a critica...
|
|
Business Update
Innovative RF Switch by Mobix Labs Wins Gold in 2024 LEAP Awards In a significant recognition of technological advancement, Mobix Labs Inc. (Nasdaq: MOBX) was awarded the prestigious Gold Award in the 2024 Leadership in Engineering Achievement Program (LEAP) Awards. Based in Irvine, California, Mobix Labs is renowne...
|
 Business Update
As the calendar inches toward that quintessential shopping extravaganza known as Black Friday, Kohl’s has surged to the forefront, unveiling its Early Access event that promises not just deals, but a chance for customers to embrace the holiday spirit with significant savings. Beginning from November 8 through Nove...
|
 Business Update
In a landscape marked by rapid technological advancement and shifting industrial landscapes, Curtiss-Wright Corporation (NYSE: CW) stands poised to engage with investors at the upcoming Baird 2024 Global Industrial Conference. Scheduled for November 14, 2024, at 9:40 a.m. CT (10:40 a.m. ET), this event will feature ...
|
|
Business Update
As the holiday season approaches, dog lovers are in for a treat as BARK (NYSE: BARK), a leading global omnichannel dog brand, unveils a slew of festive offerings designed to bring joy to both dogs and their owners. For the first time ever, BARK is introducing its popular BarkBox subscription service to retail throug...
|
Our Most Popular Articles
|
 Business Update
In an exciting new development in the field of dermatological therapeutics, Astria Therapeutics Inc. (Nasdaq: ATXS) announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for STAR-0310. This groundbreaking monoclonal antibody, an OX40 antagonist, is bein...
|
 Business Update
Expanding Horizons: JetBlue s New Caribbean Connections As JetBlue Airways makes strategic advances and fortifies its aviation empire, the skies over the Caribbean have become a significant focal point. This week, the airline marked another milestone by inaugurating a new nonstop service between New York s John F. K...
|
|
Announcement
In an unfolding legal development, investors in Maravai Lifesciences Holdings, Inc. a prominent biotech firm, are being advised to take swift action regarding a significant securities class action lawsuit. According to a recent statement from the Rosen Law Firm, a leading global investor rights law firm, the deadlin...
|
More News
|
 Business Update
Scheduling the Future: NYSE Group s Holiday Calendar and Its Broader Implications In an era where financial markets are continually abuzz with activity from dawn to dusk, the announcement of future holiday and early closing schedules by the NYSE Group a key component of Intercontinental Exchange Inc. (NYSE: ICE) off...
|
|
Business Update
Aditxt, Inc. Updates Shareholders on Strategic Financial Moves and Acquisition Efforts Amid a Reverse Stock Split MOUNTAIN VIEW, Calif. Aditxt, Inc. (NASDAQ: ADTX), a dynamic innovation platform devoted to accelerating promising health technologies, has released a significant update for its shareholders, sheddin...
|
 Product Service News
Autolus Therapeutics has recently announced the FDA approval of AUCATZYL (obecabtagene autoleucel or obe-cel) for the treatment of adults suffering from relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL). This pivotal decision follows a recognized need for more effective treatment options for ...
|
 Clinical Study
Replimune s Strategic Inducement Grants Solidify Commitment to Innovative Oncolytic Immunotherapies On November 8, 2024, Replimune Group, Inc. (NASDAQ: REPL), a pioneering entity in the field of clinical-stage biotechnology, made a significant announcement regarding its commitment to bolstering its workforce amidst ...
|
 Product Service News
Cutting-Edge CAR T-Cell Therapy: Fate Therapeutics’ Breakthrough Data and Stellar Financial Performance Set to Revolutionize Cancer TreatmentIn an era where advancements in immunotherapy are reshaping oncological treatment paradigms, Fate Therapeutics, Inc. has emerged as a frontrunner with the presentation of it...
|
 Merger and Acquisition
By Ivry-sur-Seine, France – November 8, 2024 – In a bold move signaling its commitment to expand its footprint in the Internet of Things (IoT) sector, Lantronix, a reputable name in secure data communications and management solutions, announced on November 7, 2024, the strategic acquisition of DZS’s NetComm ...
|
 Business Update
Recharging the Future: Energy Vault s Ambitious Step into Texas Energy Landscape In a pivotal move to accelerate the energy transition in the United States, Energy Vault Holdings Inc. has announced its latest venture: the deployment of a 57 MW/114 MWh Battery Energy Storage System (BESS) project in Scurry County, T...
|
 Clinical Study
Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company specializing in oncology, continues to advance its research portfolio despite facing significant financial hurdles. At the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting held in Houston, Texas, from November 6-10, 2...
|
 Announcement
Envoy Medical Expands Intellectual Property Portfolio with New European Patent for Advanced Cochlear Implant System WHITE BEAR LAKE, Minnesota, Nov. 08, 2024 Envoy Medical, Inc. (NASDAQ: COCH), a pioneer in the development of fully implanted hearing systems, has announced a significant milestone in its quest to ...
|
 Contract
In a bold strategic move, Diana Shipping Inc. an eminent player in the global shipping arena, has secured a significant time charter contract for its Ultramax dry bulk vessel, m/v DSI Pyxis. This recent development comes at a time when the shipping industry faces turbulent waters, with the company s latest financial...
|
 Announcement
In an era characterized by rapid technological advancement and increasing cyber threats, SEALSQ Corp, a Swiss-based company specializing in semiconductors and post-quantum technology, has emerged as a beacon of innovation. Announcing a secure digital identity ecosystem on November 8, 2024, SEALSQ aims to bolster 5G ...
|
 Clinical Study
: Kineta, a biotechnology company focused on developing innovative therapies for cancer and other diseases, recently presented updated clinical results from its ongoing Phase 1/2 VISTA101 study of KVA12123 at the Society for Immunotherapy of Cancer (SITC) 2024. This article outlines the key findings from the prese...
|
 Business Update
Bruker Corporation (Nasdaq: BRKR), a leading innovator in scientific instrumentation, has recently announced a series of significant advancements that underscore its commitment to enhancing research capabilities in spatial proteomics and drug discovery. These developments aim to propel Bruker to the forefront of life sciences technology, with the unveiling of EpicIF™ technology for its CellScape platform, a strategic investment in NovAliX, and the resolution of an injunction affecting its NanoString business in Germany. EpicIF™ Technology: A Game Changer in Spatial ProteomicsAt the heart of Bruker’s latest announcement is the introduction of EpicIF™, a revolutionary fluorescence signal removal technology designed to enhance the CellScape Precise Spatial Proteomics platform, one of the company’s flagship products launched in 2022. The CellScape platform has already made waves in the scientific community due to its unique ability to combine high-resolution imaging with exceptional quantitative performance. With the integration of EpicIF™, researchers can expect even more refined imaging results, thereby enhancing the accuracy and reliability of protein analysis in complex biological samples.
|
 Product Service News
EHang s Pilotless eVTOL Achieves Milestone in Thailand Amidst Financial HurdlesIn a significant step forward for Urban Air Mobility (UAM), EHang Holdings Limited, a leading technology platform company in the field, successfully completed maiden passenger flights of its EH216-S eVTOL aircraft in Thailand. This miles...
|
 Partnership
Potbelly s Expansion Plans: A Look at Financial Performance and Growth Prospects in Georgia In a strategic move for growth, Potbelly Corporation has announced its plans to expand into Georgia through a 15-unit development agreement. As the beloved sandwich chain seeks to strengthen its presence, its recent financial...
|
 Contract
Christchurch, New Zealand, Nov. 08, 2024 Innovation and technology are at the forefront of modern facilities management, and SIMPPLE Ltd. a trailblazer in this sector, is making significant strides in the industry with its latest strategic moves. The company, listed on NASDAQ under the symbol SPPL, is renowned for i...
|
|
|
|
|
